Understanding Your Insurance: When Coverage Becomes an Obstacle Instead of a Protection
Health insurance is supposed to work as a backstop — something that steps in when you need care so a diagnosis doesn’t also become a financial catastrophe. For a growing number of patients, though, the experience feels different: a doctor recommends treatment, and then the insurance company itself becomes the thing standing between the patient and that treatment. This isn’t just a feeling. It shows up in lawsuits, government audits, and the insurers’ own numbers.
This piece is meant to help you understand why that happens — not with any one insurer, but with the private insurance system broadly — so that when it happens to you, you recognize it for what it is and know how to respond.
First, What Kind of Plan Do You Actually Have?
Not all private insurance behaves the same way, and knowing your plan type tells you what to expect:
- HMO (Health Maintenance Organization): Requires a primary care physician referral to see specialists, and typically requires prior authorization on top of that referral for procedures, imaging, and surgery. The most gatekeeping of the common plan types.
- PPO (Preferred Provider Organization): No referral required to see a specialist, but prior authorization is still commonly required for higher-cost procedures, imaging, and surgery.
- EPO (Exclusive Provider Organization): Similar to a PPO in flexibility, but with no out-of-network coverage at all except emergencies.
- POS (Point of Service): A hybrid — referral requirements like an HMO, but some out-of-network flexibility like a PPO.
Whatever letters are on your card, the common thread across nearly all of them today is the same: prior authorization — the insurer’s internal approval step before it will pay for a recommended treatment.
The Approval Process Was Supposed to Be a Safety Check. It’s Become a Business Function.
Prior authorization exists, in principle, to confirm that a recommended treatment is medically necessary and appropriate before the insurer pays for it. In practice, it has increasingly become an automated cost-control function — and the recent history of the industry shows why patients are right to be skeptical of how it’s being applied.
The AI algorithm lawsuits. UnitedHealth is currently defending a class-action lawsuit alleging that it used an artificial intelligence tool called nH Predict to deny post-acute and rehabilitation care to Medicare Advantage members, allegedly overriding physicians’ own treatment plans. Plaintiffs in that case cite an internal error rate on appealed denials of roughly 90 percent — meaning nine out of ten denials that were actually challenged were later reversed. Cigna faced a separate lawsuit over an internal system called PxDx, which plaintiffs allege let the company deny payment in batches of hundreds or thousands of claims at a time. Humana has faced comparable allegations. These aren’t fringe accusations — they are active, litigated cases working through federal courts.
The numbers behind the pattern. A congressional investigation found that one major insurer denied approximately 32% of prior authorization requests for its Medicare Advantage members — far above the industry’s blended average — and that roughly 75% of those denied claims were overturned when patients appealed them. Separately, a KFF analysis found that members appealed only about 0.2% of denied claims in a recent year — meaning most denials, even ones that likely would have been reversed, are simply never challenged.
Why this matters for you specifically: if only 1 in 500 people appeals, and most appeals succeed, then the denial itself is doing very little clinical work. What it’s doing is filtering out the claims nobody pushes back on — which has nothing to do with whether the treatment was medically necessary, and everything to do with whether the patient (or their doctor’s office) had the time and knowledge to fight it.
Regulators Have Noticed
This pattern hasn’t gone unaddressed. A new federal rule (CMS-0057-F), effective January 1, 2026, now requires Medicare Advantage, Medicaid managed care, and ACA marketplace insurers to issue specific, written reasons for denials and to make faster determinations — a direct regulatory response to years of vague denial letters and slow-walked decisions. Several states have also begun introducing legislation specifically targeting the use of unsupervised AI in coverage determinations, requiring that a licensed clinician be meaningfully involved before a denial is finalized. The fact that regulators are stepping in tells you this isn’t a matter of a few unusual cases — it’s a structural problem the system itself is now being forced to correct.
What This Means, Practically, for You
None of this means insurance is worthless, or that every denial is wrongful. Prior authorization does catch genuine cases of unnecessary or duplicate care. But it does mean the burden of proof has quietly shifted onto patients and their doctors, and the numbers say most people don’t know that burden exists.
A few things worth knowing:
- A denial is a starting point, not a verdict. Given how often initial denials are overturned, treat a denial letter as the opening move, not the final word.
- Ask whether your denial came from a person or an algorithm. You are entitled to know who — or what — made the coverage decision, and you can request a peer-to-peer review with an actual physician at the insurance company.
- Request the specific clinical criteria used to deny you. Insurers must cite a specific policy or guideline. Once you have it, your doctor’s office can address that criterion directly rather than arguing in general terms.
- Know your appeal deadlines. These vary by insurer and plan type, and missing the window can forfeit your right to challenge the decision entirely.
- For vascular conditions especially, don’t let the clock run out quietly. Conditions like peripheral artery disease can progress from manageable to urgent in weeks. A denial that sits unappealed isn’t neutral — it’s time your circulation doesn’t have.
Our Role
At South Florida Vascular Associates, navigating this system is part of our job, not yours. Our staff routinely requests peer-to-peer reviews, pulls the specific clinical policy an insurer cites, and builds appeals around it — because we’ve seen, again and again, that a denial is often just the first answer, not the right one. If you’ve been told “no” by your insurance company, talk to us before you accept that as final.
This article is intended for general educational purposes and does not constitute medical, legal, or insurance advice. If you are experiencing symptoms of a vascular emergency — sudden limb pain, numbness, coldness, or discoloration — seek emergency care immediately.
Dr. Julien has performed more than 40,000 vascular procedures across a 30-year career. Double board-certified in Interventional Radiology and Diagnostic Radiology by the American Board of Radiology, he is the co-founder and past president of the Outpatient Endovascular & Interventional Society, a national faculty speaker at SIR, TCT, VIVA, and the Southeastern Angiographic Society, and a published author. Named a Boca Magazine Top Doctor 2025.
